Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 11,068,000 | 10,540,000 | 10,129,000 | 10,781,000 | 7,945,000 |
| Cost of Goods | 2,910,000 | 2,502,000 | 2,699,000 | 3,662,000 | 2,492,000 |
| Gross Profit | 8,158,000 | 8,038,000 | 7,430,000 | 7,119,000 | 5,453,000 |
| Operating Expenses | 18,609,000 | 5,781,000 | 5,803,000 | 7,423,000 | 5,582,000 |
| Operating Income | -10,451,000 | 2,257,000 | 1,627,000 | -304,000 | -129,000 |
| Pre-tax Income | -10,451,000 | 2,257,000 | 1,627,000 | -304,000 | -129,000 |
| Income Tax | -424,000 | 379,000 | 1,707,000 | 462,000 | 931,000 |
| Net Income Continuous | -10,027,000 | 1,878,000 | -80,000 | -766,000 | -1,060,000 |
| Minority Interests | N/A | 6,000 | 5,000 | 9,000 | -4,000 |
| Net Income | $-10,027,000 | $1,872,000 | $-85,000 | $-775,000 | $-1,056,000 |
| EPS Basic Total Ops | -4.44 | 0.83 | -0.04 | -0.34 | -0.74 |
| EPS Basic Continuous Ops | -4.44 | 0.83 | -0.04 | -0.34 | -0.74 |
| EPS Diluted Total Ops | -4.43 | 0.82 | -0.04 | -0.34 | -0.73 |
| EPS Diluted Continuous Ops | -4.43 | 0.82 | -0.04 | -0.34 | -0.74 |
| EBITDA(a) | $-7,761,000 | $4,912,000 | $4,185,000 | $2,173,000 | $1,107,000 |